Natural history of LGMD2A for delineating outcome measures in clinical trials
Natural history of LGMD2A for delineating outcome measures in clinical trials
About this item
Full title
Author / Creator
Publisher
United States: Wiley
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wiley
Subjects
More information
Scope and Contents
Contents
Objective
Limb‐girdle muscular dystophy 2A (LGMD2A, OMIM) is a slowly progressive myopathy caused by the deficiency in calpain 3, a calcium‐dependent cysteine protease of the skeletal muscle.
Methods
In this study, we carried out an observational study of clinical manifestations and disease progression in genetically confirmed LGMD2A patie...
Alternative Titles
Full title
Natural history of LGMD2A for delineating outcome measures in clinical trials
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4818744
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4818744
Other Identifiers
ISSN
2328-9503
E-ISSN
2328-9503
DOI
10.1002/acn3.287
